Feasibility of Action Observation and Repetitive Task Practice on Upper Extremity Outcomes in Chr… (NCT04015271) | Clinical Trial Compass
CompletedNot Applicable
Feasibility of Action Observation and Repetitive Task Practice on Upper Extremity Outcomes in Chronic Stroke Survivors
United States15 participantsStarted 2019-06-27
Plain-language summary
The objective of this pilot randomized controlled single blinded, parallel-group study is to detect change of the Action Observation (AO) and Repetitive Task Practice (RTP) combined practice schedule on upper limb motor impairment outcomes in chronic, moderately impaired stroke survivors.
Who can participate
Age range
18 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Experienced a stroke resulting in a Upper Extremity Fugl Meyer score \>17 \< 49
* Experienced a post stroke \> 6 months
* \> 24 on the Folstein Mini Mental Status Examination
* Experienced only one stroke
* Discharged from all forms of physical rehabilitation intervention
* Visual acuity of 20/50 or greater with or without corrective lenses
* \> 19 on the Hooper Visual Organization Test
* Unilateral stroke only
* Cerebral stroke
* Age of onset of stroke greater than 18 years old.
Exclusion Criteria:
* \< 18 years old
* \> 5 on a 10-point visual analog pain scale in the affected UL
* \> 2 on the Modified Ashworth Scale in the affected UL to exclude individuals with hypertonia, spasticity, joint rigidity, and joint contracture
* Participating in any experimental rehabilitation or drug studies
* Uncontrolled cardiovascular, or pulmonary disease, or other disease that would preclude involvement in a therapeutic treatment
* Neurological disorder other than stroke
* \> 31 on Beck Depression Inventory ("Severe Depression")
* Unable to regularly attend treatment sessions and follow-up due to distance from the center or inadequate social support
* Cerebellar stroke with ataxia
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change from Baseline in Upper extremity section of the Fugl-Meyer Scale
Timeframe: Pretest, immediately after the intervention, and 1 month post intervention